Zebrafish as a Model for Osteoporosis: Functional Validations of Genome-Wide Association Studies.
Inbar Ben-ZviDavid KarasikCheryl L Ackert-BicknellPublished in: Current osteoporosis reports (2023)
The true power for the use of zebrafish is the ease by which the genome can be edited, especially using the CRISPR/Cas9 system. Gene editing, followed by phenotyping, for complex traits such as BMD, is beneficial, but the major physiological differences between the fish and mammals must be considered. Like mammals, zebrafish do have main bone cells; thus, both in vivo stem cell analyses and in vivo imaging are doable. Yet, the "long" bones of fish are peculiar, and their bone cavities do not contain bone marrow. Partial duplication of the zebrafish genome should be taken into account. Overall, small fish toolkit can provide unmatched opportunities for genetic modifications and morphological investigation as a follow-up to human-first discovery.
Keyphrases
- crispr cas
- bone mineral density
- genome wide
- bone marrow
- stem cells
- genome editing
- genome wide association
- high throughput
- postmenopausal women
- induced apoptosis
- endothelial cells
- high resolution
- mesenchymal stem cells
- cell cycle arrest
- body composition
- soft tissue
- mass spectrometry
- bone loss
- cell death
- cell proliferation
- oxidative stress
- case control
- copy number
- pluripotent stem cells
- fluorescence imaging
- single cell